The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125641801 12564180 1 I 20160711 20160718 20160718 EXP US-DEPOMED, INC.-US-2016DEP011454 DEPOMED SHARMA R. FOCAL FATTY INFILTRATION OF THE LIVER AS A POSSIBLE RARE SIDE EFFECT OF GABAPENTIN: CASE REPORT OF A 14 YEAR OLD FEMALE DEVELOPING ABDOMINAL SYMPTOMS FOLLOWING INITIATION OF TREATMENT. PEDIATR RADIOL.. 2016;46(1 SUPPL):S209 14.00 YR F Y 0.00000 20160715 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125641801 12564180 1 PS GABAPENTIN. GABAPENTIN 1 Oral 1-2 100MG CAPSULES, TID 22544

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125641801 12564180 1 Ear pain

Outcome of event

Event ID CASEID OUTC COD
125641801 12564180 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125641801 12564180 Abdominal pain upper
125641801 12564180 Hepatic steatosis
125641801 12564180 Nausea
125641801 12564180 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found